211 related articles for article (PubMed ID: 37354211)
21. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
[TBL] [Abstract][Full Text] [Related]
22. PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy.
Du X; Yi X; Zou X; Chen Y; Tai Y; Ren X; He X
BMC Cancer; 2023 Nov; 23(1):1102. PubMed ID: 37957639
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive bioinformatics analysis reveals the significance of forkhead box family members in pancreatic adenocarcinoma.
Hu W; Li M; Wang Y; Zhong C; Si X; Shi X; Wang Z
Aging (Albany NY); 2023 Jan; 15(1):92-107. PubMed ID: 36622275
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract][Full Text] [Related]
25. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
Zhang T; Sheng P; Jiang Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
[TBL] [Abstract][Full Text] [Related]
26. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
Du W; Lei C; Wang Y; Ding Y; Tian P
Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
[TBL] [Abstract][Full Text] [Related]
27. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
28. LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma.
Liu J; Wang M; Wang M; Wang F; Zhang B
Biochem Genet; 2024 Feb; 62(1):485-503. PubMed ID: 37382751
[TBL] [Abstract][Full Text] [Related]
29. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
[No Abstract] [Full Text] [Related]
30. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma.
Liu Q; Li R; Wu H; Liang Z
BMC Cancer; 2023 Mar; 23(1):226. PubMed ID: 36894917
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():758725. PubMed ID: 34804125
[No Abstract] [Full Text] [Related]
32. Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation.
Qiao S; Wu F; Wang H
Cancer Rep (Hoboken); 2024 Jun; 7(6):e2108. PubMed ID: 38837874
[TBL] [Abstract][Full Text] [Related]
33. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract][Full Text] [Related]
34. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
Xu Q; Zheng J; Su Z; Chen B; Gu S
BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
[TBL] [Abstract][Full Text] [Related]
35. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
36. Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma.
Zhang LL; He QK; Lv YN; Zhang ZJ; Xiang YK
Chronobiol Int; 2021 May; 38(5):681-693. PubMed ID: 33691542
[TBL] [Abstract][Full Text] [Related]
37. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
Li Y; Su Z; Wei B; Liang Z
Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma.
Zhong B; Ma DD; Zhang T; Gong Q; Dong Y; Zhang JX; Li ZH; Jin WD
Comb Chem High Throughput Screen; 2024; 27(7):1011-1021. PubMed ID: 37563820
[TBL] [Abstract][Full Text] [Related]
39. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
Li Y; Liu Z; Zhang Y
BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
